RxDoctor Payments Data

Austin Williams, MD

Family Medicine · Marksville, LANPI 1265994222

Payments from drug & device makers

$1,161in general payments, 2019–2025

Across 62 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$192
  • AbbVie$177
  • Teva Pharmaceuticals USA, Inc.$114
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$107
  • Lilly USA, LLC$92
  • Axsome Therapeutics, Inc.$90
  • plus $389 from 12 others

What the payments were for

  • Food & beverage$1,161100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,161 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$8,488
Medicare patients
55
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$100,185
Trelegy ElliptaFluticasone/Umeclidin/Vilanter104$74,551
JardianceEmpagliflozin72$71,188
TrulicityDulaglutide53$67,189
EliquisApixaban35$24,330
VraylarCariprazine Hcl27$17,550
NuedextaDextromethorphan Hbr/Quinidine22$17,220
RexultiBrexpiprazole21$16,617
FarxigaDapagliflozin Propanediol21$13,857
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl48$8,160
EntrestoSacubitril/Valsartan22$7,881
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$6,843
Pantoprazole Sodium174$6,320
BrilintaTicagrelor11$5,828
Sildenafil Citrate25$5,674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$84$100,185106 claims
GSKTrelegy Ellipta, Anoro Ellipta$52$81,394119 claims
Lilly USA, LLCTrulicity$92$67,18953 claims
PfizerEliquis$13$24,33035 claims
AstraZenecaFarxiga, Brilinta$192$19,68532 claims
AbbVieVraylar$177$17,55027 claims
Otsuka America Pharmaceutical, Inc.Rexulti$44$16,61721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Marksville

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →